The trendline should drive prices to the next target at USD 151.
From a fundamental viewpoint, the company is really strong. During the past 12 months the Thomson Reuters consensus revised regularly upward EPS estimates of the company for 2013 and 2014(respectively +50% and +68%). The great business predictability emphasize the quality of this investment in the mid-term.
Technically, the security shows a bullish configuration on all time scales. Prices are supported by increasing moving averages and this configuration should drive prices to our next target around USD 151(swing effect).
Therefore, taking into account the strong fundamentals and technical patterns, it seems opportune to take a long position at the crossing of the USD 138,7 resistance. The target price is USD 151 and the trendline should imply a gradual increase. A stop loss will be placed under the USD 138,7.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Companyâs Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.